Novel investigational therapies for atopic dermatitis

KS Ibler, GBE Jemec - Expert Opinion on Investigational Drugs, 2015 - Taylor & Francis
Introduction: Atopic dermatitis (AD) is a common skin disease. Although most patients are
well served by existing therapies, a subset of patients with severe AD are still not adequately …

Emerging treatment options in atopic dermatitis: topical therapies

U Nygaard, M Deleuran, C Vestergaard - Dermatology, 2018 - karger.com
Atopic dermatitis is a chronic inflammatory skin disorder affecting children and adults, with
the majority presenting mild to moderate disease severity. The use of topical corticosteroids …

Insights into future therapeutics for atopic dermatitis

T Edwards, NU Patel, A Blake… - Expert Opinion on …, 2018 - Taylor & Francis
ABSTRACT Introduction: Atopic Dermatitis (AD) is a common chronic inflammatory skin
disorder with a constellation of symptoms. Currently, there are numerous therapies in …

New therapies for atopic dermatitis: Additional treatment classes

PP Vakharia, JI Silverberg - Journal of the American Academy of …, 2018 - Elsevier
Background A wide array of miscellaneous agents is being studied for the treatment of
atopic dermatitis (AD), including targeted topical, oral systemic, and biologic agents …

Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials

X Yang, N Kambe, R Takimoto-Ito… - Pharmacology & …, 2021 - Elsevier
Atopic dermatitis (AD) is an inflammatory skin disease arising from a complex interplay of
genetic, immune, and environmental factors. The development and successful marketing of …

Updated review on treatment of atopic dermatitis

JC Armario Hita, M Galán-Gutiérrez, JM Dodero-Anillo… - 2023 - rodin.uca.es
Atopic dermatitis (AD) is a chronic or chronically recurrent Inflammatory dermatosis
associated with multiple triggers that has a complex pathophysiological mechanism. It is …

A systematic review of atopic dermatitis: the intriguing journey starting from physiopathology to treatment, from laboratory bench to bedside

G Radi, A Campanti, F Diotallevi, E Martina, A Marani… - Biomedicines, 2022 - mdpi.com
Atopic dermatitis (AD) is a common chronic inflammatory and immune-mediated skin
disease with a complex pathophysiology and still represents a therapeutic challenge, owing …

New and emerging biologics for atopic dermatitis

W Baghoomian, CH Na, EL Simpson - American Journal of Clinical …, 2020 - Springer
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is characterized by
complex pathophysiology involving both skin barrier dysfunction and aberrant type 2 …

[HTML][HTML] A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis

K Waligóra-Dziwak, A Dańczak-Pazdrowska… - Journal of Clinical …, 2024 - mdpi.com
Atopic dermatitis (AD) is a skin condition characterized by significant challenges and a
substantial deterioration in the life quality for affected patients. The therapeutic landscape for …

[HTML][HTML] Therapeutic new era for atopic dermatitis: part 2. Small molecules

J Ahn, Y Choi, EL Simpson - Annals of Dermatology, 2021 - ncbi.nlm.nih.gov
Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disease driven by immune
dysregulation and skin barrier dysfunction. Currently, we are experiencing a new era of …